Atlas Trials

Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma

Clinical trial NCT03457389 · UNKNOWN

Trial details

NCT number
NCT03457389
Sponsor
Seoul National University Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Pituitary AdenomaProlactinomaPituitary TumorRecurrence Tumor
Start date
2018-02-22
Primary completion
2024-12-31
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.